Chimerix EBITDA per Share | CMRX

Annual EBITDA per Share Chimerix

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
-1.08	-1.05	-0.69	-2.04	-0.71	-2.08	-1.46	-1.51	-1.66	-2.68	-1.78	-1.47	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.69	-2.68	-1.52

Quarterly EBITDA per Share Chimerix

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-0.28	-0.25	-0.27	-	-0.3	-0.24	-0.27	-	0.13	-0.27	-0.28	-0.45	-0.21	-0.21	-1.21	-0.19	-0.18	-0.16	-0.17	-0.06	-1.27	-0.36	-0.37	-0.3	-0.33	-0.39	-0.42	-0.39	-0.36	-0.36	-0.39	-0.33	-0.36	-0.39	-0.57	-0.83	-0.7	-0.59	-0.54	-0.52	-0.47	-0.38	-0.38	-0.3	-0.24	-0.33	-4.22	-2.7	7.51	-2.82	-3.57	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.51	-4.22	-0.46

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
AbbVie ABBV	8.95	$ 263.04	0.49 %	$ 465 B	USA
AbCellera Biologics ABCL	-0.67	$ 11.41	2.15 %	$ 3.41 B	Canada
Фармсинтез LIFE	-0.23	-	-	-	Russia
Aclaris Therapeutics ACRS	-0.62	$ 5.53	6.02 %	$ 678 M	USA
ADC Therapeutics SA ADCT	-0.95	$ 1.09	3.74 %	$ 139 M	Schweiz
Amryt Pharma plc AMYT	-0.16	-	-	$ 621 M	Britain
Evelo Biosciences EVLO	-1.22	-	-14.46 %	$ 27.9 M	USA
Allakos ALLK	-1.29	-	-	$ 28.6 M	USA
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
Clovis Oncology CLVS	-0.34	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	-2.21	-	-	$ 401 M	USA
ADMA Biologics ADMA	0.84	$ 8.61	0.16 %	$ 2.05 B	USA
Eiger BioPharmaceuticals EIGR	-48.4	-	-9.21 %	$ 2.55 M	USA
89bio ETNB	-3.67	-	-	$ 1.55 B	USA
Freeline Therapeutics Holdings plc FRLN	-1.63	-	-	$ 384 M	Britain
Fusion Pharmaceuticals FUSN	-1.49	-	-	$ 1.41 B	Canada
Guardion Health Sciences GHSI	-3.4	-	-0.31 %	$ 3.64 M	USA
Genocea Biosciences GNCA	-0.74	-	-15.0 %	$ 3.04 M	USA
Gritstone Oncology GRTS	-1.14	-	0.42 %	$ 213 M	USA
G1 Therapeutics GTHX	-0.75	-	-	$ 370 M	USA
Harpoon Therapeutics HARP	-1.99	-	-	$ 763 M	USA
Humanigen HGEN	-0.77	-	-81.12 %	$ 4.28 M	USA
HOOKIPA Pharma HOOK	-3.88	-	-6.92 %	$ 79.4 M	USA
Intercept Pharmaceuticals ICPT	-0.54	-	-	$ 643 M	USA
IGM Biosciences IGMS	-3.3	-	-	$ 76.9 M	USA
IMV IMV	-0.28	-	-	$ 13.1 M	Canada
Intra-Cellular Therapies ITCI	-1.13	-	-	$ 13.6 B	USA
Kinnate Biopharma KNTE	-2.58	-	-	$ 123 M	USA
Chinook Therapeutics KDNY	-2.82	-	-	$ 2.6 B	USA
Kaleido Biosciences KLDO	-2.04	-	-3.69 %	$ 12.4 M	USA
Kronos Bio KRON	-1.52	-	1.49 %	$ 50.8 M	USA
Karuna Therapeutics KRTX	-13.3	-	-	$ 12.2 B	USA
Landos Biopharma LABP	-3.62	-	0.58 %	$ 144 M	USA
La Jolla Pharmaceutical Company LJPC	0.8	-	-	$ 154 M	USA
LogicBio Therapeutics LOGC	-1.18	-	-	$ 229 M	USA
Lumos Pharma LUMO	-4.49	-	-	$ 35.3 M	USA
Merrimack Pharmaceuticals MACK	-0.14	-	-	$ 216 M	USA
Stealth BioTherapeutics Corp MITO	-0.07	-	-	$ 23.9 M	USA
Mirati Therapeutics MRTX	-13.5	-	-	$ 3.3 B	USA
NexImmune NEXI	-30.4	-	70.13 %	$ 4.12 M	USA
9 Meters Biopharma NMTR	-3.24	-	-42.97 %	$ 1.05 M	USA
InVivo Therapeutics Holdings Corp. NVIV	-6.89	-	-37.48 %	$ 476 K	USA
Nymox Pharmaceutical Corporation NYMX	-0.05	-	-19.68 %	$ 18.4 M	Canada
ObsEva SA OBSV	-1.79	-	-15.52 %	$ 10.5 M	Schweiz
Oncorus ONCR	-2.81 K	-	-8.54 %	$ 3.19 M	USA
OncoSec Medical Incorporated ONCS	-0.94	-	31.87 %	$ 1.61 M	USA
Oncternal Therapeutics ONCT	-14.2	-	-24.12 %	$ 1.56 M	USA
Opiant Pharmaceuticals OPNT	1.18	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	-0.97	-	1.02 %	$ 90.8 M	Britain